Business ❯ Corporate Governance ❯ Board of Directors ❯ Executive Leadership

Strategic Management

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

The move puts Korsana’s Alzheimer’s antibody on a funded path to first human data in 2027.